Trial Information
International Cooperative Metabolic Study (iNCMS) of NutropinAq® [Somatropin (rDNA Origin) Injection] Replacement Therapy in Adults With Growth Hormone Deficiency
Inclusion Criteria:
- Patients with Growth Hormone Deficiency
- Patients treated with NutropinAq®
- Patients having completed growth (fused epiphyses)
Exclusion Criteria:
- Active neoplasia
- Pregnancy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Incidence of serious adverse events
Outcome Time Frame:
when reported
Safety Issue:
Yes
Principal Investigator
Pascale Dutailly, MD
Investigator Role:
Study Director
Investigator Affiliation:
Ipsen
Authority:
Germany: Federal Institute for Drugs and Medical Devices
Study ID:
2-79-58035-006
NCT ID:
NCT00455884
Start Date:
June 2006
Completion Date:
December 2011
Related Keywords:
- Growth Hormone Disorders
- Dwarfism, Pituitary
- Endocrine System Diseases
